NIH #5R00CA263149-04
Decoding glioma evolution and progression by multi-dimensional single-cell profiling
- Amount
- $249K
- Period
- 2024-07-02 → 2027-06-30
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF PENNSYLVANIA
Glioma Diagnosis and Treatment · Genetics
4 total · 2 active
NIH #5R00CA263149-04
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #4R00CA263149-03
Awarded at UNIVERSITY OF PENNSYLVANIA
NIH #5K99CA263149-02
Awarded at BROAD INSTITUTE, INC.
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
The critical role of the endogenous immune compartment after CAR T cell therapy in recurrent GBM
Cell · 2026-06-01
A cellular epigenetic classification system for glioblastoma
Neuro-Oncology · 2026-01-03
DDDR-63. Immune remodeling in CSF and tumor predicts response to CAR T therapy in glioblastoma
Neuro-Oncology · 2025-11-01
Neuro-Oncology · 2025-07-28 · 1 citations
Nature Medicine · 2025-06-11 · 3 citations
Nature Medicine · 2025-06-01 · 66 citations
Journal of Clinical Oncology · 2025-05-28 · 4 citations
Cytotherapy · 2025-04-30
Neuro-Oncology · 2024-11-01
Neuro-Oncology · 2024-11-01
Neuro-Oncology · 2024-11-01 · 1 citations